Dow Down 0.17% Nasdaq Down 0.28%

Agios Pharmaceuticals, Inc. (AGIO)

-NasdaqGS
61.35 5.15(7.74%) Sep 30, 4:00PM EDT
Prev Close:66.50
Open:66.49
Bid:57.24 x 100
Ask:63.55 x 800
1y Target Est:64.50
Beta:1.979
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:60.36 - 67.02
52wk Range:15.77 - 69.50
Volume:1,609,853
Avg Vol (3m):486,370
Market Cap:2.11B
P/E (ttm):N/A
EPS (ttm):-1.83
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AGIODown 7.74%2.11B
ALXN32.80B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):76.81
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.94
Quarterly EPS Est (Sep-14) :-0.53
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agios Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics in the field of cancer metabolism and inborn errors of metabolism (IEMs) in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback